Cancer Biomarkers

Cancer biomarkers, particular those associated with genetic mutations or epigenetic alterations, often offer a quantitative way to determine when individuals are predisposed to particular types of cancers. A cancer biomarker refers to a substance or process that is indicative of the presence of cancer in the body. A biomarker may be a molecule secreted by a tumor or a specific response of the body to the presence of cancer. Genetic, epigenetic, proteomic, glycomic, and imaging biomarkers can be used for cancer diagnosis, prognosis, and epidemiology.

    Related Conference of Cancer Biomarkers

    June 20-21, 2018

    15th European Pathology Congress

    | Paris, France
    June 25-26, 2018

    15th Congress on Pathology and Cancer Research

    | Executive Airport Plaza Hotel & Conference Centre | Vancouver | Canada
    August 29-30, 2018

    4th International Conference on Cytopathology & Histopathology

    Boston | Massachusetts | USA
    August 31 - September 01, 2018

    International Conference and Expo on Dermatopathology and Skin Diagnosis

    Toronto, Canada
    September 17-18,2018

    16th Annual Conference on Laboratory Medicine & Pathology

    Kuala Lumpur, Malaysia
    September 17-18, 2018

    16th Asia Pacific Pathology Congress

    Tokyo, Japan
    October 18-19, 2018

    Biology and Pathology of Infectious Diseases Conference

    Helsinki, Finland

    Cancer Biomarkers Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in